Dyne Therapeutics vs Viking Therapeutics: 2026 Buy Guide
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Explore how Sp 500 stacks up against the Total Stock Market for retirement investing, focusing on long-term growth, volatility, and portfolio diversification.
28,492 articlesTwo clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Nu Holdings is poised for a volatile after-hours session as it reports quarterly results. Analysts weigh margin gains...
SpaceX leaps past the $2 trillion mark as it eyes a spot in the Nasdaq-100, triggering intense debate about the susta...
Circle posted a surprising earnings beat as stablecoins attract ongoing demand, lifting circle shares and underscorin...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
Scotiabank boosted Cameco's price target to $175 as a global push for nuclear power gains traction and a new supply d...
Investors are reassessing opportunities in firearm makers as policy shifts and demand cycles test the staying power o...
Regulators have signaled close scrutiny of a possible Paramount-Warner Bros. merger, threatening delays and potential...
When AI buzz dominates markets, smart investors look abroad for durable moats. This guide explains two international ...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
UWM raises its offer for Two Harbors to $12.50 per share in cash or 2.3328 UWMC shares, aiming to derail CrossCountry...